Overview

Dosing and Tolerability of Deoxycholic Acid Versus Polidocanol in the Treatment of Neurofibromatosis Type 1 Cutaneous Neurofibromas

Status:
Recruiting

Trial end date:
2024-09-30

Target enrollment:

Participant gender:

Summary

This study will evaluate the tolerability and effectiveness of two treatments in Neurofibromatosis Type 1 Cutaneous Neurofibromas. These treatments are: Kybella and Asclera injection. Each patient will have a treatment and a control site.

Phase:

Phase 1

Details

Lead Sponsor:

Massachusetts General Hospital

Collaborator:

Johns Hopkins University

Treatments:

Deoxycholic Acid